Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.
Class II · Ongoing
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
Advertisement
Advertisement
Affected lots / codes — check yours against thisLot #: 3047, Exp Date July 2027.
- Recalling firm
- Hikma Pharmaceuticals USA INC., Columbus, OH
- Classification
- Class II (temporary or reversible harm possible)
- Status
- Ongoing
- Quantity
- 2136 bottles
- Distribution
- Nationwide within the United States
- Recall initiated
- October 6, 2026
- Classified
- October 23, 2026
- Initiation
- Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA
enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0076-2027%22
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0076-2027%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots
above against your own product. This page reproduces public FDA data for readability;
EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →